AZITRA INC

Profile

Company Names

AZITRA INC

Addresses

21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT 06405

400 FARMINGTON AVENUE, FARMINGTON, CT 06032

400 FARMINGTON AVENUE, CB 126, FARMINGTON, CT 06032

Phone Numbers

(203) 489-0183
860-679-4292
203-599-0700

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

CONNECTICUT

Total Amount Raised:

$32,074,879.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2022-09-16 
$4,350,000.00 
$4,500,000.00 
$150,000.00 
Debt 
5
2021-01-05 
$1,000,000.00 
$2,000,000.00 
$1,000,000.00 
Equity, Debt 
4
2020-09-10 
$17,000,159.00 
$17,000,159.00 
$0.00 
Equity 
3
2019-02-22 
$4,699,710.00 
$17,299,710.00 
$12,600,000.00 
Equity 
2
2018-04-13 
$2,125,000.00 
$2,500,000.00 
$375,000.00 
Debt 
1
2017-03-17 
$2,900,010.00 
$3,656,250.00 
$756,240.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICAHRD 
 
ANDREWS 
EXECUTIVE OFFICER, DIRECTOR
AZITRA INC
RICHARD 
 
ANDREWS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
LYNDEN ENERGY CORP   |  THRASOS INNOVATION INC.   |  AZITRA INC   |  GEO TICKET PORTALS, INC.
LUCIO 
 
IANNONE 
DIRECTOR
PYXIS ONCOLOGY, INC.   |  EGENESIS, INC.   |  AZITRA INC   |  IMMUNITAS THERAPEUTICS, INC.   |  DEKA BIOSCIENCES, INC.   |  AFFINI-T THERAPEUTICS, INC.
NAVEEN 
 
KRISHAN 
DIRECTOR
AZITRA INC
ANDREW 
 
MCCLARY 
DIRECTOR
AZITRA INC
CAIN 
 
MCCLARY 
DIRECTOR
CHECKERSPOT, INC.   |  AZITRA INC   |  ELEGEN CORP.
AZIM 
 
MUNIVAR 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
AZITRA INC
STELLA 
 
ROBERTSON 
DIRECTOR
AZITRA INC   |  E-MIST INNOVATIONS, INC.   |  TREFOIL THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.   |  I-LUMEN SCIENTIFIC, INC.
FRANCISCO 
 
SALVA 
EXECUTIVE OFFICER, DIRECTOR
AZITRA INC
DANIEL 
 
WAGNER 
DIRECTOR
INNOVATIENT SOLUTIONS, INC.   |  REMOTEREALITY CORP   |  NEW HAVEN PHARMACEUTICALS, INC.   |  CMDBIOSCIENCE,INC.   |  SOFT TISSUE REGENERATION, INC.   |  ISOPLEXIS CORP   |  BARPAY, LLC   |  CORNOVUS PHARMACEUTICALS INC.   |  BIOREZ, INC.   |  AZITRA INC   |  ALLOMEK THERAPEUTICS, LLC   |  PROTEOWISE INC.   |  HASTE, INC.   |  TANGEN BIOSCIENCES, INC.   |  MITOTHERAPEUTIX, LLC   |  INTUS BIOSCIENCES, LLC   |  REZOLVE AI PLC   |  ENRICH BIOSYSTEMS INC.
TRAVIS 
 
WHITFILL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
AZITRA INC   |  410 MEDICAL, INC.   |  INCYSUS THERAPEUTICS, INC.   |  IN8BIO, INC.   |  SIRPANT IMMUNOTHERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2022-09-16 
2021-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2021-01-05 
2020-09-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-10 
2019-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
2018-04-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-13 
2017-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#